This report contains market size and forecasts of Infliximab and Biosimilar in global, including the following market information:
Global Infliximab and Biosimilar Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Infliximab and Biosimilar Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Infliximab and Biosimilar companies in 2020 (%)
The global Infliximab and Biosimilar market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infliximab and Biosimilar manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infliximab and Biosimilar Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Infliximab and Biosimilar Market Segment Percentages, By Type, 2020 (%)
Infliximab
Infliximab-dyyb
Infliximab-abda

Global Infliximab and Biosimilar Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Infliximab and Biosimilar Market Segment Percentages, By Application, 2020 (%)
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis
Plaque Psoriasis

Global Infliximab and Biosimilar Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Infliximab and Biosimilar Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infliximab and Biosimilar revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Infliximab and Biosimilar revenues share in global market, 2020 (%)
Key companies Infliximab and Biosimilar sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Infliximab and Biosimilar sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Janssen Biotech
Merck and Co.
Pfizer